The Microbiome's Influence on Head and Neck Cancers.
Chemotherapy
Head and neck cancer
Immunotherapy
Microbiome
Microbiota
Oncogenesis
Radiotherapy
Toxicity
Journal
Current oncology reports
ISSN: 1534-6269
Titre abrégé: Curr Oncol Rep
Pays: United States
ID NLM: 100888967
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
accepted:
12
10
2022
pubmed:
26
1
2023
medline:
25
2
2023
entrez:
25
1
2023
Statut:
ppublish
Résumé
Head and neck tumors (HNC) rank sixth among cancers worldwide. Due to their late diagnosis and poor prognosis, they are a clinical challenge. However, recent years have seen a dynamic development of science on the microbiome. The aim of the study is to discuss the role of the microbiome in HNC, the impact of the microbiome on oncogenesis, the course of the disease, as well as on treatment, and its toxicity. The microbiome's influence on oncogenesis, the course of the disease, and the effectiveness of oncological treatment have been confirmed in cancers of the colon, pancreas, lungs, and prostate. There is no solid literature on HNC. Many studies indicate disruption of the oral microbiome and periodontal disease as potential cancer risk factors. Disruption of the microbiome increases radiotherapy's toxicity, intensifying radiation reactions. The microbiome plays an important role in cancer. It is a new target in research into new therapies. It may also be a prognostic marker of cancer development. Changes in the composition of the microbiome modulate the effectiveness of oncological treatment. More research is needed on the microbiome and its effects on HNC.
Identifiants
pubmed: 36696075
doi: 10.1007/s11912-022-01352-7
pii: 10.1007/s11912-022-01352-7
pmc: PMC9947050
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
163-171Informations de copyright
© 2023. The Author(s).
Références
Front Microbiol. 2018 May 03;9:862
pubmed: 29774014
Oncotarget. 2017 Oct 19;8(57):97273-97289
pubmed: 29228609
Front Genet. 2019 Feb 19;10:98
pubmed: 30838027
Bioeng Bugs. 2010 Nov-Dec;1(6):385-94
pubmed: 21468205
Oncotarget. 2015 Sep 8;6(26):22613-23
pubmed: 26158901
Cancer Discov. 2018 Apr;8(4):403-416
pubmed: 29567829
PeerJ. 2018 Sep 19;6:e5590
pubmed: 30294508
Front Oncol. 2018 Aug 17;8:318
pubmed: 30175072
J Med Microbiol. 2018 Aug;67(8):1058-1068
pubmed: 29923815
Oncogene. 2017 Jul 20;36(29):4182-4190
pubmed: 28346430
J Anus Rectum Colon. 2018;2(2):37-46
pubmed: 30116794
Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):E2329-38
pubmed: 24843156
Cancer. 2019 Apr 1;125(7):1081-1090
pubmed: 30521105
Front Immunol. 2021 Jan 07;11:612202
pubmed: 33488618
Technol Cancer Res Treat. 2019 Jan 1;18:1533033819867354
pubmed: 31370775
Sci Rep. 2020 Oct 6;10(1):16582
pubmed: 33024215
Transl Res. 2017 Jan;179:168-182
pubmed: 27477083
CA Cancer J Clin. 2017 Mar;67(2):122-137
pubmed: 28128848
Immunology. 2013 Mar;138(3):183-9
pubmed: 23190340
Neurol Clin. 2018 Feb;36(1):185-196
pubmed: 29157399
N Engl J Med. 2020 Jan 2;382(1):60-72
pubmed: 31893516
Ann Oncol. 2018 Jun 1;29(6):1437-1444
pubmed: 29617710
Oral Dis. 2005 May;11(3):151-6
pubmed: 15888105
Oral Oncol. 2022 Jan;124:105657
pubmed: 34915261
Carcinogenesis. 2018 May 28;39(6):778-787
pubmed: 29668903
Eur J Cancer. 2015 Oct;51(15):2130-2143
pubmed: 26421817
Nature. 2012 Jun 13;486(7402):215-21
pubmed: 22699610
Appl Environ Microbiol. 2010 Jun;76(12):3886-97
pubmed: 20418441
Cancers (Basel). 2018 Jun 22;10(7):
pubmed: 29932446
PLoS Biol. 2007 Jul;5(7):e177
pubmed: 17594176
Cancer. 2020 Dec 1;126(23):5124-5136
pubmed: 32888342
Oncotarget. 2017 Jul 18;8(29):47780-47789
pubmed: 28562354
Clin Transl Oncol. 2018 Aug;20(8):966-974
pubmed: 29313208
Periodontol 2000. 2010 Jun;53:70-88
pubmed: 20403106
Inflamm Bowel Dis. 2016 Apr;22(4):817-25
pubmed: 26937623
Oncotarget. 2017 May 16;8(20):33159-33171
pubmed: 28388539
Proc Natl Acad Sci U S A. 2010 Jun 29;107(26):11971-5
pubmed: 20566857
Clin Invest Med. 2017 Feb 19;40(1):E1-E12
pubmed: 28218577
mSystems. 2018 May 15;3(3):
pubmed: 29795809
Cancer Lett. 2018 Feb 28;415:40-48
pubmed: 29197615
Science. 2017 Dec 15;358(6369):1443-1448
pubmed: 29170280
Int J Oral Sci. 2018 Nov 12;10(4):32
pubmed: 30420594
Nutr Rev. 2012 Aug;70 Suppl 1:S10-3
pubmed: 22861801
Microbiol Immunol. 2014 Jul;58(7):375-81
pubmed: 24818822
Front Oncol. 2017 May 22;7:89
pubmed: 28589080
Lung Cancer. 2016 Dec;102:89-95
pubmed: 27987594
Sci Rep. 2018 Aug 14;8(1):12157
pubmed: 30108246
Sci Rep. 2017 Jul 14;7(1):5507
pubmed: 28710395
Science. 2020 May 29;368(6494):973-980
pubmed: 32467386
Oncogene. 2022 Feb;41(9):1269-1280
pubmed: 35087236
Sci Transl Med. 2015 Jan 21;7(271):271ps1
pubmed: 25609166
Infect Agent Cancer. 2017 Jan 13;12:4
pubmed: 28101126
Microbiome. 2015 Jul 30;3:31
pubmed: 26229597
Carcinogenesis. 2012 May;33(5):1055-8
pubmed: 22367402
Microbiome. 2018 Apr 24;6(1):59
pubmed: 29685174
Int J Cancer. 2004 Sep 10;111(4):480-3
pubmed: 15239123
Clin Microbiol Infect. 2012 Jul;18 Suppl 4:2-4
pubmed: 22647038
J Intern Med. 2000 Sep;248(3):171-83
pubmed: 10971784
Curr Obes Rep. 2016 Mar;5(1):51-64
pubmed: 26865085
Science. 2015 Nov 27;350(6264):1084-9
pubmed: 26541606
Int J Oral Sci. 2011 Oct;3(4):209-15
pubmed: 22010579
Nat Rev Urol. 2015 Feb;12(2):81-90
pubmed: 25600098
PLoS One. 2009 Oct 09;4(10):e7401
pubmed: 19816594
Front Microbiol. 2019 Jun 25;10:1050
pubmed: 31293523
Br J Cancer. 2003 Apr 7;88(7):1012-6
pubmed: 12671696
Prostate. 2013 Jun;73(9):1007-15
pubmed: 23389852
Nat Biotechnol. 2017 Sep 12;35(9):833-844
pubmed: 28898207
J Periodontol. 2015 May;86(5):656-65
pubmed: 25660499
Crit Rev Oncol Hematol. 2019 Sep;141:1-12
pubmed: 31202124
J Med Microbiol. 2007 Dec;56(Pt 12):1651-1659
pubmed: 18033835
Nature. 2014 May 1;509(7498):91-5
pubmed: 24670651
Nat Rev Gastroenterol Hepatol. 2016 Dec;13(12):691-706
pubmed: 27848961
Science. 2013 Nov 22;342(6161):971-6
pubmed: 24264990
Genome Biol. 2018 Aug 24;19(1):123
pubmed: 30143034
Curr Pharm Des. 2016;22(40):6134-6141
pubmed: 27634184
Ann Oncol. 2017 Jun 01;28(6):1368-1379
pubmed: 28368458
Ann Surg Oncol. 2018 Oct;25(11):3389-3395
pubmed: 30062471
Science. 2018 Jan 5;359(6371):91-97
pubmed: 29097494
Microbiome. 2019 Apr 13;7(1):60
pubmed: 30981280
Lancet Glob Health. 2020 Feb;8(2):e180-e190
pubmed: 31862245
Cell Rep. 2018 Sep 25;24(13):3528-3538
pubmed: 30257213
Toxins (Basel). 2017 Apr 08;9(4):
pubmed: 28397767
PLoS One. 2013;8(2):e56343
pubmed: 23437114
J Oral Maxillofac Pathol. 2018 May-Aug;22(2):234-238
pubmed: 30158777
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
J Laryngol Otol. 2016 Mar;130(3):265-71
pubmed: 26740194
Eur J Clin Microbiol Infect Dis. 2017 Nov;36(11):2073-2083
pubmed: 28600626
J Pathol. 2015 Feb;235(3):478-89
pubmed: 25348195
EBioMedicine. 2017 Apr;18:23-31
pubmed: 28216066
J Gastroenterol Hepatol. 2019 Jul;34(7):1182-1192
pubmed: 30357910
Nat Rev Cancer. 2013 Nov;13(11):800-12
pubmed: 24132111
J Clin Microbiol. 2016 Apr;54(4):934-43
pubmed: 26763956
Genome Med. 2015 Jun 24;7(1):55
pubmed: 26170900
J Natl Compr Canc Netw. 2020 Jul;18(7):873-898
pubmed: 32634781
Microbiome. 2016 Nov 1;4(1):58
pubmed: 27802830
CA Cancer J Clin. 2015 Sep-Oct;65(5):401-21
pubmed: 26215712
Science. 2013 Nov 22;342(6161):967-70
pubmed: 24264989
Arch Oral Biol. 2015 Sep;60(9):1222-30
pubmed: 26073028
N Engl J Med. 2016 Dec 15;375(24):2369-2379
pubmed: 27974040